Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema

Andrés F. Lasave, David G. Zeballos, Wael M. El-Haig, Manuel Daz-Llopis, David Salom, J Fernando Arevalo

Research output: Contribution to journalArticle

Abstract

Purpose: To report the short-term results of a single intravitreal injection of bevacizumab (IVB) versus a single intravitreal injection of triamcinolone acetonide (IVT) to treat refractory noninfectious uveitic cystoid macular edema (CME). Methods: Twenty-eight consecutive patients (36 eyes) were retrospectively included. Patients received either 2.5mg of IVB (16 eyes) or 4mg of IVT (20 eyes). Results: In the IVT group, baseline best-corrected visual acuity (BCVA) was logMAR 1.1±0.2, and improved to 0.7±0.3 (p

Original languageEnglish (US)
Pages (from-to)423-430
Number of pages8
JournalOcular Immunology and Inflammation
Volume17
Issue number6
DOIs
Publication statusPublished - Dec 2009

    Fingerprint

Keywords

  • Bevacizumab
  • Noninfectious uveitis
  • Single intravitreal injection
  • Triamcinolone acetonide
  • Uveitic cystoid macular edema

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this